HOME >> MEDICINE >> NEWS
Weizmann Institute Prof. Moshe Oren named winner of NIH MERIT Award

Washington, D.C.--Prof. Moshe Oren, a cancer researcher at the Weizmann Institute of Science in Israel, was named a 2003 winner of the highly selective MERIT (Method to Extend Research in Time) Award. The award is granted by the National Institutes of Health (NIH) for "long-term support to investigators with impressive records of scientific achievement in research areas of special importance or promise."

The NIH hopes the MERIT Award will encourage scientists to "take greater risks, be more adventurous in the lines of inquiry, or take the time to develop new techniques." Less than five percent of NIH investigators are selected to receive the MERIT Award, which provides long-term support for researchers, freeing them from the burden of securing and renewing funding for their work year after year. The award has been presented annually since 1987 to individuals whose "paradigm shifting ideas" and "excellent productivity" make them leaders in their field.

Prof. Oren's research gained the attention of the cancer research world in the early 1980s for his role in cloning p53, the "tumor suppressor gene." Since that time, p53 has been the object of intense scientific scrutiny. It soon became clear that p53 is a part of a complex molecular network, that can suppress -- or fail to suppress -- cancerous growth.

The discovery of p53 and its key role in maintaining healthy cells led to a burgeoning new direction in cancer research. Although it is not the only tumor suppressor gene, mutations in the p53 gene are most common in cancer. In normal cells, p53 sets in motion a complex series of molecular events that can cause cell suicide, or apoptosis -- which, despite its name, is a necessary and healthy mechanism that prevents damaged cells from replicating possibly cancerous mistakes in their DNA. When p53 does not function properly, cancerous cells do not undergo apoptosis, and are able to proliferate in the body. Understanding how p53 works, and
'"/>

Contact: Jeffrey J. Sussman
Jeffrey@acwis.org
212-895-7951
American Committee for the Weizmann Institute of Science
11-Nov-2003


Page: 1 2

Related medicine news :

1. Weizmann Institute receives $8 million grant from Flight Attendant Medical Research Institute
2. Weizmann Women & Science Award to be presented to Dr. Carla J. Shatz; Millennial Lifetime Achievement Award to Dr. Mildred S. Dresselhaus
3. Weizmann Institute scientists develop a potential future treatment for myasthenia gravis
4. Gladstone Institutes rank high in the scientist survey of best places for postdocs
5. Institute of Medicine advisory: Jan. 12 Briefing on Complementary and Alternative Medicine
6. Research by scientists affiliated with the Earth Institute at Columbia University
7. New Jersey Institute of Technology pioneers new way to teach engineers
8. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
9. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
10. American College of Chest Physicians announces new Critical Care Institute
11. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Weizmann Institute Prof Moshe Oren named winner NIH MERIT Award

(Date:10/31/2014)... say that either they or a family member have ... latest issue of The Gerontological Society of America,s ... which goes on to show that Americans strongly support ... end-of-life health care wishes. , This PP&AR , ... features 12 articles that present new ways of understanding ...
(Date:10/31/2014)... 31, 2014 Gold Medal Wine Club ... affordable but tasteful gifts for the wine novice and enthusiasts ... Bird Gift Giving Special , which Early Bird shoppers receive ... Wine Club Gift membership. , Gift Givers must place ... special. Besides offering discounts, Gold Medal Wine Club adds more ...
(Date:10/31/2014)... North Shore Eye Care today announced the ... and the addition of leading ophthalmologist, William S. Kasper, ... Shore Eye Care Medical Director, Jeffrey Martin, MD. , ... Department of Ophthalmology of Winthrop-University Hospital and has maintained ... more than 30 years. He has been named to ...
(Date:10/31/2014)... drug combination that can trigger the self-destruct process in ... treatments, according to research that will be presented at ... Liverpool next week*. , When healthy cells are no ... in self destruction. But cancer cells swerve away from ... cells grow out of control – causing tumours to ...
(Date:10/31/2014)... 2014 FindSurrogateMother.com conveys a ... of life — building a family through surrogacy. The ... and donors with hopeful intended parents in turn generating ... It’s a collective aptitude of surrogate mothers, intended parents, ... fertility clinics that help provide these connections — and ...
Breaking Medicine News(10 mins):Health News:Advance directives can benefit patients, families, and health care system 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Scientists trigger self-destruct switch in lung cancer cells 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
(Date:10/31/2014)... , Oct. 30, 2014 Migranade, Inc. announced ... be available to the 36 million U.S. migraine sufferers ... technology that targets the actual cause of migraines and ... pain and not the source Migranade is assured to ... MIGRANADE Migraine Relief is available at http://www.migranade.com ...
(Date:10/31/2014)...  AbbVie (NYSE: ABBV ) today ... Sept. 30, 2014. "Our third-quarter ... with double-digit growth from HUMIRA and several other ... percent in the quarter excluding lipids," said Richard ...  "We exceeded our outlook for the quarter and ...
(Date:10/30/2014)... , Oct. 30, 2014 WuXi PharmaTech (Cayman) ... R&D capability and technology platform company serving the pharmaceutical, ... China and the United ... representative office in the Tel Aviv ... office will promote WuXi,s broad platform of integrated R&D ...
Breaking Medicine Technology:Game Changing Migraine Medication To Be Available November 2014 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2
Cached News: